Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.12 -0.01 (-0.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Other Accumulated Expenses (2018 - 2026)

Updated

Adial Pharmaceuticals (ADIL) posted Other Accumulated Expenses of $1.46 million for Q2 2026, up 291.1% from $372,560 a year earlier and up 74.0% from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Adial Pharmaceuticals' Other Accumulated Expenses came in at $660,000, up 62.9% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
  • In prior years, Adial Pharmaceuticals' Other Accumulated Expenses was $405,246 in FY2024 (-3.8%), $421,365 in FY2023 (-44.7%), $761,509 in FY2022 (+46.2%) and $520,795 in FY2021 (+61.5%).
  • The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last six quarters, with growth averaging 83.7% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2026, with growth of 291.1%; the weakest was Q1 2024, with a decline of 82.1%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $837,509 (Q1 2026), $660,000 (Q4 2025) and $513,169 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Adial Pharmaceuticals 19.04 Mn 19.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.46 Mn
Mar 31, 2026 837,509.00
Dec 31, 2025 660,000.00
Sep 30, 2025 513,169.00
Jun 30, 2025 372,560.00
Mar 31, 2025 588,442.00
Dec 31, 2024 405,246.00
Sep 30, 2024 413,557.00
Jun 30, 2024 273,578.00
Mar 31, 2024 196,118.00
Dec 31, 2023 421,365.00
Sep 30, 2023 354,107.00
Jun 30, 2023 276,705.00
Mar 31, 2023 1.09 Mn
Dec 31, 2022 761,509.00
Sep 30, 2022 686,501.00
Jun 30, 2022 498,628.00
Mar 31, 2022 357,535.00
Dec 31, 2021 520,795.00
Sep 30, 2021 444,564.00
API Access

Adial Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ADIL&period=max&api_key=YOUR_API_KEY